Related Experiment Video
Updated: Oct 22, 2025

Using Confocal Analysis of Xenopus laevis to Investigate Modulators of Wnt and Shh Morphogen Gradients
Published on: December 14, 2015
Identification of disease-relevant modulators of the SHH pathway in the developing brain
Nora Mecklenburg1, Izabela Kowalczyk1, Franziska Witte2
1Disorders of the Nervous System, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
Abstract:
Pathogenic gene variants in humans that affect the sonic hedgehog (SHH) pathway lead to severe brain malformations with variable penetrance due to unknown modifier genes. To identify such modifiers, we established novel congenic mouse models. LRP2-deficient C57BL/6N mice suffer from heart outflow tract defects and holoprosencephaly caused by impaired SHH activity. These defects are fully rescued on a FVB/N background, indicating a strong influence of modifier genes. Applying comparative transcriptomics, we identified Pttg1 and Ulk4 as candidate modifiers upregulated in the rescue strain. Functional analyses showed that ULK4 and PTTG1, both microtubule-associated proteins, are positive regulators of SHH signaling, rendering the pathway more resilient to disturbances. In addition, we characterized ULK4 and PTTG1 as previously unidentified components of primary cilia in the neuroepithelium. The identification of genes that powerfully modulate the penetrance of genetic disturbances affecting the brain and heart is likely relevant to understanding the variability in human congenital disorders.
Insights
Genetic modifiers like ULK4 and PTTG1 help regulate the sonic hedgehog (SHH) pathway, influencing brain and heart development. These findings aid in understanding human congenital disorders.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Pathogenic variants in the sonic hedgehog (SHH) pathway cause severe brain malformations with variable penetrance.
- The underlying genetic modifiers influencing this variability are largely unknown.
Purpose of the Study:
- To identify modifier genes that influence SHH pathway activity and congenital malformations.
- To characterize the function of novel modifier genes in neurodevelopment and heart development.
Main Methods:
- Generation of congenic mouse models to study genetic modifiers.
- Comparative transcriptomics to identify candidate modifier genes.
- Functional analyses of candidate genes (Pttg1, Ulk4) in mouse models.
Main Results:
- LRP2-deficient mice on a C57BL/6N background exhibit heart and brain defects due to impaired SHH signaling.
- These defects were fully rescued in LRP2-deficient mice on an FVB/N background, indicating strong genetic modulation.
- Pttg1 and Ulk4 were identified as upregulated candidate modifiers in the rescue strain.
- ULK4 and PTTG1 were confirmed as positive regulators of SHH signaling and components of primary cilia.
Conclusions:
- ULK4 and PTTG1 act as crucial positive regulators of SHH signaling, enhancing pathway resilience.
- These genes are novel components of primary cilia, important for neuroepithelial function.
- Understanding these modifiers is key to explaining variability in human congenital disorders affecting brain and heart development.
More Related Videos
Related Concept Videos
Hedgehog Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

